ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
Vancouver Coastal Health at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
Vancouver Coastal Health takes part in 3 sessions at ASHI 2026 in Montréal. Its work links HLA class I leader peptide mismatches to T-cell mediated rejection in cytomegalovirus-positive kidney recipients and studies missing-self HLA ligands for inhibitory KIR in kidney graft survival. It also joins a look at balancing infection and rejection in the era of the microbiome.
| Organization | ASHI 2026 Attendance |
|---|---|
Vancouver Coastal Health Vancouver, BC | |
Regional health authority running hospitals and community care in Vancouver and surrounding British Columbia communities. | Talk Wed Oct 28 4:00pm–4:15pm HLA Class I Leader Peptide Mismatches Associate with T-cell Mediated Rejection and Microvascular Inflammation in Cytomegalovirus-Seropositive Kidney Transplant Recipients: A single-centre British Columbia cohort study Bioinformatics, AI and risk modelingSolid organ transplantation Session Thu Oct 29 4:15pm–5:45pm Workshop 5: Transplant Balancing Act: Navigating Infection and Rejection in the Era of the Microbiome Solid organ transplantation Poster The Effect of Missing Self HLA Class I Ligands to Inhibitory Killer Cell Ig-Like Receptors in a Large Cohort Study of Kidney Transplant Allograft Survival HLA typing, sequencing and genotypingSolid organ transplantation |
Find decision makers at Vancouver Coastal Health
Tell us what you sell and we’ll find the people at Vancouver Coastal Health most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction